CAH

Cardinal Health, Inc.
$235.80
+2.03 (+0.87%)
Mkt Cap 55.23B
Volume 1,904,531
52W Range 137.75-243.21
Sector Healthcare
Beta 0.49
EPS (TTM) 6.56
P/E Ratio 35.95
Revenue (TTM) 250.55B
Rev Growth (5Y) +7.8%
EPS Growth (5Y) +4.5%
AlphaVal · Fair Value
What we estimate one share is worth
$152.06
Overvalued strong signal
55.1% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
62.4 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 222.58B 226.83B 204.98B 181.33B 162.47B 152.92B 145.53B 136.81B 129.98B 121.55B 102.53B 91.08B
Net Income 1.56B 852.00M 330.00M (938.00M) 611.00M (3.69B) 1.36B 256.00M 1.29B 1.43B 1.22B 1.17B
EPS 6.48 3.48 1.26 -3.34 2.09 -12.60 4.54 0.82 4.06 4.36 3.66 3.42
Free Cash Flow 1.85B 3.25B 2.36B 2.73B 2.03B 1.58B 2.39B 2.38B 797.00M 2.51B 2.24B 2.27B
FCF / Share 7.68 13.27 9.05 9.80 6.95 5.41 7.98 7.62 2.51 7.66 6.75 6.67
Operating CF 2.40B 3.76B 2.84B 3.12B 2.43B 1.96B 2.72B 2.77B 1.18B 2.97B 2.54B 2.52B
Total Assets 53.12B 45.12B 43.35B 43.88B 44.45B 40.77B 40.96B 39.95B 40.11B 34.12B 30.14B 26.03B
Total Debt 9.35B 5.61B 5.18B 5.80B 6.71B 6.78B 8.03B 9.01B 10.39B 5.54B 5.49B 3.97B
Cash & Equiv 3.87B 5.13B 4.08B 4.72B 3.41B 2.77B 2.53B 1.76B 6.88B 2.36B 4.62B 2.87B
Book Value (2.78B) (3.21B) (2.96B) (709.00M) 1.79B 1.79B 6.33B 6.06B 6.81B 6.55B 6.26B 6.40B
Return on Equity N/A N/A N/A N/A 0.34 -2.06 0.22 0.04 0.19 0.22 0.19 0.18
CAH News
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
Jul 10, 2026 06:30 AM · zacks.com
Should You Retain CAH Stock After Removal From Several Russell Indices?
Jul 09, 2026 11:26 AM · zacks.com
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11
Jul 09, 2026 02:45 AM · prnewswire.com
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
Jul 08, 2026 03:16 PM · zacks.com
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Jul 06, 2026 09:09 AM · fool.com
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating
Jul 03, 2026 10:55 AM · seekingalpha.com
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Jul 03, 2026 06:41 AM · zacks.com
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
Jul 02, 2026 06:51 AM · zacks.com
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Jul 01, 2026 06:41 AM · zacks.com
Why the Market Dipped But Cardinal Health (CAH) Gained Today
Jun 26, 2026 03:02 PM · zacks.com